Thus, our suggested mechanism for anaemia in ESRD patients is that an increased level of TTR could induce TTR aggregates, inhibiting transferrin endocytosis, this, in turn, decreases intracellular iron, reducing erythropoiesis and leading to anaemia. The gene discussed is TTR; the disease is anemia.